Insider Selling: KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) CEO Sells $86,071.45 in Stock

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) CEO Benjamin L. Palleiko sold 7,465 shares of the firm’s stock in a transaction that occurred on Friday, June 7th. The shares were sold at an average price of $11.53, for a total transaction of $86,071.45. Following the completion of the transaction, the chief executive officer now […]

Leave a Reply

Your email address will not be published.

Previous post Verint Systems Inc. (NASDAQ:VRNT) Director William Kurtz Sells 2,110 Shares
Next post Insider Buying: Beyond, Inc. (NYSE:BYON) Chairman Acquires $97,779.60 in Stock